Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Care India is a healthcare provider specializing in regenerative medicine and advanced stem cell therapies. Headquartered in Mumbai, India, the organization focuses on treating a wide range of chronic and debilitating conditions that often have limited options in conventional medicine. Their therapeutic portfolio includes treatments for neurological disorders such as autism, cerebral palsy, and motor neuron disease, as well as orthopedic conditions like osteoarthritis. The company utilizes autologous stem cell transplantation, primarily sourcing cells from the patient's own bone marrow or adipose tissue to minimize rejection risks. Cell Care India operates clinical facilities where they integrate cell processing with specialized medical care to provide personalized treatment protocols. Their mission is to improve the quality of life for patients through the application of cutting-edge biotechnology and regenerative clinical practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Care India.